Compare · EGLX vs MEDS
EGLX vs MEDS
Side-by-side comparison of Enthusiast Gaming Holdings Inc. (EGLX) and DataMeds AI Inc. (MEDS): market cap, price performance, sector, and recent activity on the wire.
Summary
- EGLX operates in Miscellaneous, while MEDS operates in Health Care - the two are in different parts of the market.
- MEDS carries a market cap of $7.6M.
- MEDS has hit the wire 7 times in the past 4 weeks while EGLX has been quiet.
- EGLX has more recent analyst coverage (5 ratings vs 1 for MEDS).
- Company
- Enthusiast Gaming Holdings Inc.
- DataMeds AI Inc.
- Price
- -
- -
- Market cap
- -
- $7.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 0
- 7
- Recent ratings
- 5
- 1
Enthusiast Gaming Holdings Inc.
Enthusiast Gaming Holdings Inc. engages in the media, content, entertainment, and esports businesses the United States, Canada, and internationally. The company operates an online network of approximately 100 gaming related websites; owns and operates Enthusiast Gaming Live Expo, a video-gaming expo; provides management and support services to players involved in professional gaming; and owns and manages esports teams, which cover games comprising Call of Duty, Madden, Fortnite, Overwatch, Apex, and Valorant; and produces and programs approximately 30 weekly shows across AVOD and OTT channels, and represents approximately 500 gaming influencers across YouTube and Twitch. It also operates Luminosity Gaming, an eSports franchise; and hosts other gaming events. The company is headquartered in Toronto, Canada.
DataMeds AI Inc.
DataMEDS AI, Inc. (NASDAQ:MEDS), formerly Wellgistics Health, Inc., is a healthcare company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units through its health information technology platforms to deliver a better experience for consumers and providers. Headquartered in Tampa, Fla., DataMEDS incorporates its EinsteinRx artificial intelligence platform and PharmacyChain blockchain-enabled smart contracts platform into the Health Lives Here mobile application from Tollo Health, LLC, and its pharmacy-related Corexa Health subsidiary provides pharmacy dispensing and pharmacy-related services, including distribution of products developed by Tollo Health. DataMEDS also owns Helomics Corporation, a Pittsburgh, PA -based commercial clinical molecular diagnostics laboratory focused on the ChemoFx Assay chemotherapy selection diagnostics test that aims to help oncologists make chemotherapy treatment decisions.
Latest EGLX
- SEC Form 15F-12B filed by Enthusiast Gaming Holdings Inc.
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
- SEC Form S-8 POS filed by Enthusiast Gaming Holdings Inc.
- SEC Form F-10/A filed by Enthusiast Gaming Holdings Inc. (Amendment)
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
- SEC Form 6-K filed by Enthusiast Gaming Holdings Inc.
Latest MEDS
- DataMEDS AI Agrees to Acquire TBIA Cancer AI Blood Test Platform From Todos Medical Estate for Subsidiary Helomics, Inc.
- UPDATING ORIGINAL RELEASE DataMEDS AI Releases CEO Letter
- DataMEDS AI Releases CEO Letter
- DataMEDS AI Reports 50% Sequential Revenue Growth in Third Quarter 2026 From Second Quarter 2026, Delivers Net Profit Per Share of $2.72 and Provides Business Update
- DataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMO
- DataMEDS AI Announces Termination of Second Amended and Restated Letter of Intent
- DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
- DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
- Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License
- DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies